Document is current
Any future updates will be listed below
-
Authors
Sun, Guangyu
Chen, Xingchi
Pan, Tianzhong
Song, Kaidi
Xie, Haicun
Tu, Meijuan
Wan, Xiang
Yao, Wen
Cheng, Yaxin
Zhou, Ziwei
Wang, Dongyao
Han, Yongsheng
Tang, Baolin
Yang, Liming
Zhu, Xiaoyu
-
Funding
Funding for this research was provided by:
Ruichuang Biotechnology Co., Ltd.
National Natural Science Foundation of China (U23A20453, 82270223 and 82170209)
Anhui Provincial Key Research and Development Project (2022e07020015)
Anhui Health Research Project (AHWJ2022a011)
Anhui Provincial Department of Education Scientific Research Project (2023AH010079, 2022AH030128)
Anhui Provincial Natural Science Foundation (2308085J09)
International Cooperation Projects in Anhui Province (2023h11020005)
- License Information
-
More Information
Article History
Received: 26 May 2025
Accepted: 10 June 2025
First Online: 2 July 2025
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee of the First Affiliated Hospital of the University of Science and Technology of China.
: All authors are consent for publication.
: Liming Yang & Haicun Xie are employed by Ruichuang Biotechnology Co., Ltd., Shaoxing, China. Liming Yang is inventor of several DNT technology-related patents and intellectual properties. The remaining authors declare no competing interests.
